Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Xetra  >  Aurubis    NDA   DE0006766504


News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Aurubis : The underlying trend remains to the downside

share with twitter share with LinkedIn share with facebook
share via e-mail
02/11/2019 | 02:49am EDT
short sell
Stop-loss triggered
Entry price : 45.98€ | Target : 40€ | Stop-loss : 51€ | Potential : 13.01%
The declining trend in the stock price that has been seen for a number of trading sessions, should not be expected to reach a turning point over the coming days.
Investors should open a short trade and target the € 40.
Aurubis : The underlying trend remains to the downside
  • In a short-term perspective, the company has interesting fundamentals.

  • The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at EUR 43.22 EUR in weekly data.
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.16 for the 2019 fiscal year.
  • Its low valuation, with P/E ratio at 8.94 and 8.5 for the ongoing fiscal year and 2020 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The company is one of the best yield companies with high dividend expectations.
  • For the last week, the earnings per share forecast has been revised upwards. According to recent estimates, analysts give a positive overview of the stock
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

  • According to Thomson-Reuters' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • For the last four months, EPS estimates made by Thomson-Reuters analysts have been revised downwards.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • The underlying tendency is negative on the weekly chart below the resistance at 56.8 EUR
Stocks mentioned in the article
ChangeLast1st jan.
AURUBIS 3.07% 45.04 Delayed Quote.1.11%
THOMSON REUTERS CORPORATION -0.34% 86.85 Delayed Quote.32.19%

Ulrich Ebensperger
© Zonebourse.com 2019
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (EUR)
Sales 2019 11 103 M
EBIT 2019 200 M
Net income 2019 147 M
Debt 2019 35,5 M
Yield 2019 3,28%
P/E ratio 2019 13,6x
P/E ratio 2020 12,2x
EV / Sales2019 0,19x
EV / Sales2020 0,16x
Capitalization 2 025 M
Upcoming event on AURUBIS
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 11
Average target price 44,70  €
Last Close Price 45,04  €
Spread / Highest target 33,2%
Spread / Average Target -0,75%
Spread / Lowest Target -25,2%
EPS Revisions
Roland Harings Chief Executive Officer
Fritz Vahrenholt Chairman-Supervisory Board
Thomas Bünger Chief Operating Officer
Rainer Verhoeven Chief Financial Officer
Jan Koltze Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
AURUBIS1.11%2 189
IMERYS-22.25%2 882
GEM CO LTD--.--%2 650